Evidence map›Paper›PMID 38658181›Full record

ArticleClinical and translational allergy2024

Comorbidities of chronic rhinosinusitis in children and adults.

Aada Murtomäki, Alma Helevä, Paulus Torkki, Jari Haukka, Anna Julkunen-Iivari, Riikka Lemmetyinen, Mika Mäkelä, Aarno Dietz, Mikko Nuutinen, Sanna Toppila-Salmi

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Characterising Sinonasal Pneumatization in Patients with Nasal Septal Deviation: A CBCT-Based Study.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  8. Review
  9. Comorbidities of chronic rhinosinusitis in children and adults.Clinical and translational allergy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Aada MurtomäkiInflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID https://orcid.org/0009-0002-5295-1572
Alma HeleväInflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID https://orcid.org/0009-0000-7289-358X
Paulus TorkkiDepartment of Public Health, University of Helsinki, Helsinki, Finland.
Jari HaukkaDepartment of Public Health, University of Helsinki, Helsinki, Finland.
Anna Julkunen-IivariInflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Riikka LemmetyinenInflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Mika MäkeläInflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Aarno DietzDepartment of Otorhinolaryngology, University of Eastern Finland, Jouensuu, Kuopio, Finland.
Mikko NuutinenInflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Sanna Toppila-SalmiInflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID https://orcid.org/0000-0003-0890-6686
University of Helsinki · FIUniversity of Eastern Finland · FI

Funding

Allergy Research FoundationFinnish Society of Allergology and ImmunologyState funding for university-level health research TYH2019322The Finnish ORL-HNS FoundationThe Jalmari and Rauha Ahokas FoundationThe Jane and Aatos Erkko FoundationThe Paulo FoundationThe Tampere Tuberculosis FoundationThe Väinö and Laina Kivi Foundation
6 · The paper itself

Abstract

backgroundChronic rhinosinusitis (CRS) is a chronic inflammatory disease of the nose and paranasal sinuses lasting ≥12 weeks. CRS may exist with (CRSwNP) or without (CRSsNP) nasal polyps. The aim was to evaluate conditions associated with CRS in a randomized hospital cohort. We hypothesized that comorbidities and surgical procedures differ between pediatric and adult patients.

methodsThis study consisted of hospital registry data of a random sample of rhinosinusitis patients (age range 0-89 years) with the diagnosis of J32 or J33, correspondingly, registered during outpatient visits from 2005 to 2019 (n = 1461). The covariates of interest were collected from electronic health records based on ICD-10 codes and keyword searches.

resultsAmong pediatric patients (n = 104), the relative proportions of CRSsNP and CRSwNP were 86% and 14% respectively. The relative proportions of adult patients (n = 1357) with CRSsNP and CRSwNP were 60% and 40%, respectively. The following comorbidities significantly differed (p < 0.05) between pediatric and adult populations: allergy, chronic otitis media, and tonsillar diseases. In total, 41 % of the children and 46% of the adults underwent baseline endoscopic sinus surgery (ESS). Additional surgeries of the ear, nose and pharynx were significantly more common among children compared with adults. Risk of revision after baseline ESS was associated (p < 0.05) with allergy, asthma, eosinophilia, CRSwNP, immunodeficiency or its suspicion, non-steroidal anti-inflammatory drug exacerbated respiratory disease, and number of any diseases ≥2.

conclusionsOur study showed that comorbidities differ between pediatric and adult rhinosinusitis patients, as allergy, asthma and allergy, chronic otitis media, mental health disorders, and tonsils disease were significantly more prevalent among pediatric patients. Children and adults were equally treated with ESS. Notably, children underwent additional surgery on adenoids and tonsils more frequently. The effectiveness of ESS in multimorbid adults should be assessed at an individual level.

Indexed as

allergyasthmachronic rhinosinusitisnon‐steroidal anti‐inflammatory drug exacerbated respiratory diseaserhinitis

Identifiers

PMID38658181
PMCPMC11043011
OpenAlexW4395466405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.